Vetivex 11 Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Special precautions for use in animals:
Do not use unless the solution is clear, free from visible particles, and the container is undamaged. A risk of thrombosis with intravenous infusion should be considered.
Maintain aseptic precautions.
The product should be warmed to approximately 37°C prior to administration in order to avoid hypothermia.
This product should be used with caution in animals with cardiac or renal impairment as sodium overload may occur.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Use during pregnancy or lactation:
Use under veterinary supervision.
Interaction with other medicinal products and other forms of interaction:
This product in incompatible with methylprednisolone, and sodium lactate or sodium bicarbonate intravenous infusions. It is generally recommended that no agents should be added.
Overdose (symptoms, emergency procedures, antidotes):
Monitor fluid output.
This product is incompatible with methylprednisolone, and sodium lactate or sodium bicarbonate intravenous infusions.
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
There is currently no usage information available for this product. We apologize for any inconvenience.
There is currently no drug history available for this drug.
1 ml contains:
|Sodium lactate||3.17 mg|
|Sodium chloride||6.00 mg|
|Potassium chloride||0.40 mg|
|Calcium chloride dihydrate||0.27 mg|
Sodium: 131 mmol/litre, Potassium: 5 mmol/litre, Calcium: 2 mmol/litre, Bicarbonate (as lactate): 29 mmol/litre, Chloride: 111 mmol/litre. Solution for infusion. Clear, colourless solution.